The Sequoia Fund ( SEQUX), a large-cap blend fund, has been an able performer for a long time, sporting an amazing 9.7% average annual return over the past 15 years. Its heaviest weighting now is in the health-care sector, at 27% of the fund, versus the 11% of its large-blend fund category peers, followed by a 23% consumer-cyclical weighting, compared to the average 8.4% weighting of its peers. The fund has lost 3% over the past month, but is up 3% over the past three months and 7.9% this year. The $4.3 billion fund holds only 31 stocks and has relatively low 23% annual turnover. The top holdings are: drug maker Valeant Pharmaceuticals ( VRX), 13.7%; Warren Buffett's conglomerate Berkshire Hathaway ( BRK.A), 9.3%; discount-clothing retailer TJX Cos. ( TJX), 6%; construction-products maker Fastenal ( FAST), 5.5%; and Idexx Laboratories ( IDXX), a veterinary diagnostic laboratory business, at 4.8%.